Courtagen
Gene Panel Analysis Refines Risky Genes in Neurodevelopmental Disorder Cases Marked by Epilepsy
Investigators used gene panel sequence data to look at rare de novo variant frequencies in potential risk genes for neurodevelopmental disorders with epilepsy.
The number of US states legalizing cannabis for medical and recreational use is growing, expanding the market for pathogen detection solutions.
Courtagen Closes Genetic Testing Business, Citing Regulatory, Reimbursement Challenges
Going forward, the company will focus on its wholly owned subsidiary Medicinal Genomics Corporation, which conducts cannabis genetics research.
Medicinal Genomics, Courtagen Receive NIDA Grant to Detect Toxins in Cannabis
The SBIR Phase 1 award will go toward developing a test using immuno-PCR technology to detect toxins in medical marijuana.
Courtagen Life Sciences, Certainty Health Collaborate on Neurological Disorders
The two firms are collaborating on a system to share genotypic, phenotypic, and treatment outcomes data with physicians on a mobile-device network.
Jul 15, 2015
Courtagen Raises $20M
Jun 17, 2015
Courtagen Raises $7.5M
Jun 25, 2014
Bioinn to Distribute Courtagen's NGS Tests in Taiwan
Jun 20, 2014
Courtagen Raises $6.3M
Nov 1, 2012
Jul 20, 2012
Jul 11, 2012
Jul 3, 2012
Jun 25, 2012